Sigma-Aldrich Pays Sangamo $1M ZFN Milestone

Jan 13, 2009

NEW YORK (GenomeWeb News) — Sigma-Aldrich has paid Sangamo BioSciences a $1 million milestone as part of a deal for Sangamo to develop zinc finger nuclease reagents for the research market, Sangamo said this week.

The payment was a production milestone under an agreement the companies made in July 2007.

ZFNs can be designed to target any gene in any organism, Sangamo said, and can be used to rapidly make precise changes to a cell's characteristics

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Microsoft, But the Brain, Too

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

Been Reclassified

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

Pursuit of a Cancer Vaccine

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

This Week in Cell

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Main menu